Microbiome Therapeutic <i>Lactiplantibacillus plantarum</i> PMC105 for Systemic Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections: Oral and Inhalation Efficacy <i>In Vivo</i>. [PDF]
Sarafraz F +6 more
europepmc +1 more source
Epidemiology and resistance mechanisms of tigecycline- and carbapenem-resistant <i>Enterobacteriaceae</i> in China: a multicentre genome-based study. [PDF]
Yan L +10 more
europepmc +1 more source
Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC β-lactamase in P. mirabilis [PDF]
Dunne, Jr., W. Michael +4 more
core +1 more source
Ceftazidime-avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. [PDF]
Chen J, Hu Q, Zhou P, Deng S.
europepmc +1 more source
Aztreonam Acts as a Synergist for Ceftazidime/Avibactam Against Carbapenem-Resistant <i>Enterobacteriaceae</i> (CRE) of Various Carbapenemase Phenotypes in Southwestern China. [PDF]
Ruan X +9 more
europepmc +1 more source

